Patrick McIlvenny
Senior VP of Finance, Chief Accounting Officer & Principal Accounting OfficerMr. Patrick McIlvenny is Senior VP of Finance & Chief Accounting Officer of Autolus Therapeutics plc from November 2025 and serves as its Principal Accounting Officer since November 7, 2025. Mr. McIlvenny was Senior Vice President & Chief Accounting Officer of Horizon Therapeutics Public Limited Company since November 11, 2022 and served as its Senior Vice President & Deputy Chief Accounting Officer since May 05, 2022 until November 11, 2022. He joined the Horizon Therapeutics Public Limited in February 2015 as Vice President, Corporate Controller. He served as Group Head of Corporate Reporting at Ardagh Group S.A. between 2013 and 2015 and in various finance roles of increasing responsibilities at Elan Corporation plc from 2005 to 2013. Prior to joining Elan, Mr. McIlvenny worked with PricewaterhouseCoopers and with Deloitte. Mr. McIlvenny is a Fellow of the Institute of Chartered Accountants in England and Wales and earned a Bachelor of Business Studies from the University of Ulster.
Positions
- Company NameAutolus Therapeutics plcStock CodeAUTLPositionSenior VP of Finance, Chief Accounting Officer & Principal Accounting OfficerColleagues
- CMChristian Martin ItinCEO & Director
- MWMichael Weston BonneyIndependent Chairman of the Board
- MPMartin PuleFounder, Senior VP & Chief Scientific Officer
- RFRobert F. DolskiSenior VP & CFO
- CVChristopher VannSenior VP & COO
- LCLinda Cathavina BainIndependent Non-Executive Director
- CMCynthia Marie ButittaIndependent Non-Executive Director
- WDWilliam Douglas YoungIndependent Non-Executive Director
